These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9742031)

  • 41. [Overcoming weaknesses in therapy. Protease inhibitors with high IQ].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():96-7. PubMed ID: 11373795
    [No Abstract]   [Full Text] [Related]  

  • 42. Ritonavir-boosted protease inhibitors, Part 1: strategies for balancing efficacy with effects on lipids.
    Cohen CJ
    AIDS Read; 2005 Sep; 15(9):462-5, 470-1, 474, 477. PubMed ID: 16170876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Would switching the protease inhibitors (PI) to tenoforvir be an option in controlling hypertriglyceridaemia secondary to PIs? A case report.
    Alcaide ML; Kolber M; Jayaweera D
    Int J STD AIDS; 2002 Nov; 13(11):795-6. PubMed ID: 12437905
    [No Abstract]   [Full Text] [Related]  

  • 44. Ritonavir and fluticasone: beware of this potentially fatal combination.
    Li AM
    J Pediatr; 2006 Mar; 148(3):294-5. PubMed ID: 16615953
    [No Abstract]   [Full Text] [Related]  

  • 45. Using ritonavir with indinavir in cases of virologic failure.
    TreatmentUpdate; 2001; 12(12):7. PubMed ID: 11570095
    [No Abstract]   [Full Text] [Related]  

  • 46. [No resistance even after 1 year. New drug combination against HIV].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():108. PubMed ID: 11373766
    [No Abstract]   [Full Text] [Related]  

  • 47. Ritonavir impairs lipoprotein lipase-mediated lipolysis and decreases uptake of fatty acids in adipose tissue.
    den Boer MA; Berbée JF; Reiss P; van der Valk M; Voshol PJ; Kuipers F; Havekes LM; Rensen PC; Romijn JA
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):124-9. PubMed ID: 16269669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug interactions. Amprenavir with low-dose ritonavir.
    TreatmentUpdate; 2006; 18(3):9-10. PubMed ID: 17211921
    [No Abstract]   [Full Text] [Related]  

  • 49. Acquired macroglossia due to lopinavir/ritonavir treatment.
    Vritsali E; Kolokotronis A; Valagouti D; Miteloudis G; Zaraboukas T; Kioses V; Antoniades D
    J Oral Pathol Med; 2005 Jan; 34(1):56-8. PubMed ID: 15610408
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [An option even for patients with multiple pretreatment].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():97. PubMed ID: 11373796
    [No Abstract]   [Full Text] [Related]  

  • 51. Gemfibrozil effectively lowers protease inhibitor-associated hypertriglyceridemia in HIV-1-positive patients.
    Hewitt RG; Shelton MJ; Esch LD
    AIDS; 1999 May; 13(7):868-9. PubMed ID: 10357393
    [No Abstract]   [Full Text] [Related]  

  • 52. Acute pancreatitis in HIV-infected patients: are etiologies changing since the introduction of protease inhibitor therapy?
    Bush ZM; Kosmiski LA
    Pancreas; 2003 Jul; 27(1):e1-5. PubMed ID: 12826911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spontaneous bleeding associated with the use of the protease inhibitor ritonavir in a hemophiliac patient with human immunodeficiency virus infection.
    Hagerty SL; Ascher DP
    Pediatr Infect Dis J; 1998 Oct; 17(10):929-30. PubMed ID: 9802643
    [No Abstract]   [Full Text] [Related]  

  • 54. Parotid lipomatosis in HIV positive patients: a new clinical disorder associated with protease inhibitors.
    Olivé A; Salavert A; Manríquez M; Clotet B; Moragas A
    Ann Rheum Dis; 1998 Dec; 57(12):749. PubMed ID: 10070278
    [No Abstract]   [Full Text] [Related]  

  • 55. Hypermenorrhea associated with ritonavir.
    Nielsen H
    Lancet; 1999 Mar; 353(9155):811-2. PubMed ID: 10459969
    [No Abstract]   [Full Text] [Related]  

  • 56. Sexual dysfunction secondary to gemfibrozil.
    James CW; Wu TS; McNelis KC
    Pharmacotherapy; 2002 Jan; 22(1):123-5. PubMed ID: 11794424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increase of atherogenic plasma profile in HIV-infected patients treated with protease inhibitor-containing regimens.
    Bonnet F; Savès M; Droz C; Peuchant E; Chêne G; Beylot J; Morlat P
    J Acquir Immune Defic Syndr; 2000 Oct; 25(2):199-200. PubMed ID: 11103052
    [No Abstract]   [Full Text] [Related]  

  • 58. Ritonavir-induced acute kidney injury: kidney biopsy findings and review of literature.
    Shafi T; Choi MJ; Racusen LC; Spacek LA; Berry C; Atta M; Fine DM
    Clin Nephrol; 2011 Feb; 75 Suppl 1(0 1):60-4. PubMed ID: 21269596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Protease inhibitors connected to diabetes].
    Meijer van Putten JB
    Ned Tijdschr Geneeskd; 1997 Jul; 141(28):1405-6. PubMed ID: 9380204
    [No Abstract]   [Full Text] [Related]  

  • 60. Hepatotoxicity associated with ritonavir.
    Picard O; Rosmorduc O; Cabane J
    Ann Intern Med; 1998 Oct; 129(8):670-1. PubMed ID: 9786823
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.